Demonstration of in vivo bioequivalence of a generic albuterol metered- dose inhaler to ventolin

Chest

Volumn 117, Issue 3, 2000, Pages 714-721

  Stewart, Barbara A ^a   Ahrens, Richard C ^b,f   Carrier, Steve ^d,e   Frosolono, Michael ^d,e   Lux, Cheri ^b   Han, Seung Ho ^b   Milavetz, Gary ^c  

^a Healthcare Professional Associates   (United States)

^b Division of Cardiac Anesthesia   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Norton Healthcare   (United Kingdom)

^e Baker Norton Pharmaceuticals Inc   (United States)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

Albuterol; Asthma; Bronchial provocation tests; Histamine

Indexed keywords

HISTAMINE; SALBUTAMOL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ASTHMA; BIOEQUIVALENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0034097509     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.3.714     Document Type: Article

References (23)

1. 1 National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma; clinical practice guidelines, component 3. Bethesda, MD: National Institutes of Health, April 1997; Publication No. 97-405
2. 2 Top 200 drugs. In: 1997 Drug topics red book. Montvale, NJ: Medical Economics, 1997; 124
3. 3 Hindle M, Chrystyn H. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices. Thorax 1994; 49:549-553
4. 4 Hindle M, Newton DA, Chrystyn H. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung. Thorax 1993; 48:607-610
5. 5 Hindle LM, Newton DA, Chrystyn H. Dry powder inhalers are bioequivalent to metered-dose inhalers: a study using a new urinary albuterol (salbutamol) assay technique. Chest 1995; 107:629-633
6. 6 Food and Drug Administration. Interim guidance for documentation of in vivo bioequivalence of albuterol aerosols (metered-dose inhalers). Rockville, MD: Division of Bioequivalence, Office of Generic Drugs, Food and Drug Administration; January 27, 1994; Publication No. 1-27
7. 7 Chrystyn H. Standards for bioequivalence of inhaled products. Clin Pharmacokinet 1994; 26:1-6
8. 8 Dockhorn R, Vanden Burgt JA, Ekholm BP, et al. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma. J Allergy Clin Immunol 1995; 96:50-56
9. 9 Finney DJ. Statistical methods in biological assay. 3rd ed. London, UK: Charles Griffin & Co, 1978; 69-147
10. 10 Ahrens RC. On comparing β-adrenergic agonists. Ann Allergy 1991; 67:296-298
11. 11 Ahrens RC, Harris JB, Milavetz G, et al. Use of bronchial provocation with histamine to compare the pharmacodynamics of inhaled albuterol and metaproterenol in asthmatic patients. J Allergy Clin Immunol 1987; 79:876-882
12. 12 Ahrens RC, Nelson JS, Lux G, et al. A method for determining bioequivalence of β-agonist metered-dose inhalers [abstract]. J Allergy Clin Immunol 1992; 89(suppl):340
13. 13 Nelson JS, Ahrens RC, Ecklund P, et al. Are albuterol (A) and pirbuterol (P) delivered by metered-dose inhaler (MDI) therapeutically equivalent? [abstract]. J Allergy Clin Immunol 1992; 89(suppl):345
14. 14 Ahrens RC, Parks DP, Milavetz G, et al. Relative potency of inhaled albuterol and terbutaline for the inhibition of methacholine-induced bronchospasm [abstract]. J Allergy Clin Immunol 1990; 85(suppl):144
15. 15 Harris JB, Ahrens RC, Milavetz G, et al. Relative potencies and rates of decline in effect of inhaled albuterol (A) and terbutaline (T) [abstract]. J Allergy Clin Immunol 1986; 77(suppl):147
16. 16 Committee on Diagnostic Standards for Non-Tuberculosis Respiratory Disease: definition and classification of chronic bronchitis, asthma, and pulmonary emphysema; American Thoracic Society. Am Rev Respir Dis 1962; 85:762-768
17. 17 Standardization of spirometry, 1994 update: American Thoracic Society. Am J Respir Crit Care Med 1995; 152:1107-1136
18. 18 Cockcroft DW, Killian DN, Mellon JJ, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7:235-243
19. 19 Parks DP, Ahrens RC, Weinberger MM. Histamine challenges repeated at 1 1/2-2 hours do not induce tachyphylaxis [abstract]. Am Rev Respir Dis 1989; 139:A590
20. 20 Blake KV, Hoppe M, Harman E, et al. Relative amount of albuterol delivered to lung receptors from a metered-dose inhaler and nebulizer solution: bioassay by histamine bronchoprovocation. Chest 1992; 101:309-315
21. 21 Finney DJ. Statistical methods in biological assay. 3rd ed. London, UK: Charles Griffin & Co, 1978; 1-12
22. 22 Efron B, Tibshirani RJ. Bootstrap bioequivalence and power calculations: a case history. New York, NY: Chapman & Hall, 1993; 372-391
23. 23 Ahrens RC, Hendeles L, Clarke W, et al. Therapeutic equivalence of Spiros DPI and Ventolin MDI: a bioassay using methacholine. Am J Respir Crit Care Med 1999; 160:1238-1243